To test the effect of burn injury in mice congenitally deficient in interferon gamma (IFN-␥) and as well as in wild-type animals treated with IFN-␥ neutralizing antibody.
Summary Background Data
The mechanisms underlying muscle wasting following burn trauma are incompletely characterized, although the hypercatabolic state is a consequence of increased proteasomal degradation. Concurrently, burn injury results in an immunocompromised state, and subsequent infections are the leading cause of morbidity and mortality in these patients. IFN-␥, best conceptualized as a macrophage activating protein, modulates a variety of biologic pathways potentially relevant to muscle wasting and immune dysfunction.
Methods
Mice received either a 20% total body surface area burn or a control sham treatment. At days 1, 2, and 7 following treat-ment, skeletal muscle, peripheral blood, and spleen were harvested from both groups. Protein synthesis and degradation rates were measured. Lymphocyte subpopulation expression of major histocompatibility complex I (MHC I) molecules was assessed by flow cytometry, and proliferation capacity was measured using mixed lymphocyte reaction.
Results
IFN-␥ is critically involved in burn-induced weight loss; moreover, absence of IFN-␥ virtually abolished skeletal muscle hypercatabolism following burn injury. Lymphocyte proliferation and MHC I expression in the setting of burn trauma are also normalized in the absence of IFN-␥. Both antigen presentation and proliferation functions are independently affected.
Conclusions
IFN-␥ plays a fundamental role in mediating the hypercatabolic state of multiple cell types following burn trauma.
Following burn trauma, prolonged negative nitrogen balance and severe muscle wasting occur secondary to a marked increase in cellular protein catabolism. Previous investigations revealed an imbalance in the protein-amino acid equilibrium in the skeletal muscle as the cause for the loss of nitrogen from the body via urinary excretion. Specifically, there is accelerated protein turnover in skeletal muscle due to increased proteolysis, with the ubiquitinproteasome pathway accounting for the majority of observed changes; the peak effect is typically seen in the first week following injury. 1 Severe trauma is also frequently associated with immune dysfunction in the 7 to 10 days following injury; infection and subsequent multiorgan dysfunction syndrome are the leading cause of morbidity and mortality in this setting. 2, 3 The mechanisms underlying immune dysfunction in particular are the focus of substantial (and conflicting) investigation. 4 We previously demonstrated that burn injury induces a hypercatabolic state in both skeletal muscle and lymphoid cell populations and suggested similar proteolytic pathways in both. Such alterations in intracellular proteolysis, including antigen processing and presentation, as well as costimulator expression, could underlie impaired immune responses. 4 As muscle wasting occurs at sites distant from the trauma site, understanding the systemic proteolysis-inducing factor or factors is critical for developing effective therapies. A variety of circulating factors have been implicated including prostaglandins, 5 interleukin-1 (IL-1), 6 IL-6, 7,8 and tumor necrosis factor (TNF)-␣. 9,10 However, none of these have been demonstrated to have a causal role in muscle wasting or immunosuppression. 10, 11 Interestingly, most of these mediators are produced by macrophages after activation by interferon gamma (IFN-␥), a pleiotropic cytokine. 12 This upstream mediator of macrophage activation is increased approximately 24 to 48 hours after injury, correlating with maximal muscle wasting; systemic IFN-␥ levels subsequently drop to values below normal for the next few days. 13 Apart from macrophage activation, IFN-␥ also modulates a variety of other biologic pathways relevant to muscle wasting and immune dysfunction. Administration of IFN-␥ to normal rats increases ubiquitin mRNA expression in skeletal muscles, 14 and mice with disrupted IFN-␥ have impaired nitric oxide production. 15 Also, IFN-␥ changes the substrate specificity of intracellular proteolysis in the MHC I pathway by increasing the transcription of selected proteasomal subunits, 16 and regulates the expression levels of surface molecules such as MHC II. 12 The focus of this study was to evaluate the role of IFN-␥ in muscle wasting and immune dysfunction. We therefore tested the effect of burn injury in mice congenitally deficient in IFN-␥ 17 and also in wild-type (WT) animals treated with IFN-␥ neutralizing antibody (from XMG1.2 cell line). The results demonstrate that IFN-␥ modulates burn-induced weight loss as well as hypercatabolism in both skeletal muscle system and immune cells. 14 C-phenylalanine and 3 H-thymidine were obtained from ICN Biomedicals (Irvine, CA). 1-nitroso 2-napthol and ethylene dichloride were from Aldrich (Allentown, PA). FITCconjugated rat antimouse CD11b (Integrin ␣ M Chain, Mac-1 ␣ chain, clone M1/70), CD19 (anti-B cell, clone 1D3), PE-conjugated anti-IA b (for MHC class II), CD4 (L3T4, clone GK 1.5), and cychrome-conjugated anti-CD3 were obtained from Pharmingen (San Diego, CA). FITCconjugated rat antimouse F4/80 (anti-macrophages and monocytes, clone C1: A3-1) and PE-conjugated anti-H2k b (for MHC class I) were from Serotec, Inc. (Raleigh, NC). Anti-IFN-␥ neutralizing antibody was produced using the cell line XMG1.2 and purified using size exclusion column. Purity was confirmed using gel electrophoresis, concentration was determined using bicinchonic acid assay (PIERCE Chemicals, Rockford, IL), and the activity was quantified using ELISA and the commercially available antibody as a standard (#554431, Pharmingen, San Diego, CA).
METHODS

Antibodies and Reagents
Animals, Burn Injury, and Antibody Administration
Breeding pairs of WT C57/BL6 and IFN-␥ -/-mice were obtained from Jackson Laboratory (Bar Harbor, ME), and the colonies were maintained in house under 12-hours light/ dark cycle ambient conditions, with water and sterile PICO-VAC lab mouse diet (Purina Mills, Inc., St. Louis, MO) ad libitum. Male BALB/c mice were obtained from Charles River Laboratory (Wilmington, MA). In all experiments, 8to 10-week-old (22-24 g) male animals were used. Animal care was provided in accordance with the NIH guidelines, and all procedures were carried out with the approval of Massachusetts General Hospital Subcommittee on Research Animal Care.
Burn and sham injuries were performed on the dorsum of animals using the previously described protocol. 4 For the group of WT animals receiving XMG1.2 antibody treatment, 250 g antibody was administered during resuscitation. The efficacy of this dosage in blocking IFN-␥ activity was described previously. 18 The survival rate for all the groups was greater than 95%. Two of 18 burned IFN-␥ -/animals showed signs of infection; these occurred in the burned 7-day group (2 of 6 animals); there was an elevated circulating neutrophil count and these animals had decreased activity, accompanied by protein loss more than two standard deviations; results from these two animals were excluded from the final analysis. No infection was in any other group, including anti-INF-␥-treated burn animals.
Tissue Preparation, Protein Synthesis, and Degradation Measurements
One, 2, and 7 days postinjury, mice were killed using ketamine/xylazine. Tissues were harvested and prepared as described previously; 4 protein synthesis and degradation rates were measured as described previously. 4 In brief, extensor digitorum longus (EDL) and soleus muscles from both legs were dissected with intact tendons, weighed, and placed in tubes containing 3 mL ice-cold Krebs Henseleit bicarbonate (KHB) buffer (NaCl 120 mmol/L, NaHCO 3 25 mmol/L, KCl 4.8 mmol/L, KH 2 PO 4 1.2 mmol/L, CaCl 2 2.5 mmol/L, and MgSO 4 1.2 mmol/L [0.14], pH ϭ 7.4) saturated with 5% CO 2 /95% O 2 . Care was taken to handle muscle tissue only at the tendons. The total number of viable cells cultured in 35-mm culture dishes was 5 ϫ 10 6 splenocytes or 10 6 peripheral blood mononuclear cells (PBMNCs).
Flow Cytometry Analysis of Lymphoid Subpopulations and MHC I and II Expressions
A total of 10 6 cells from each lymphoid population (splenocytes or PBMNCs) were washed with phosphatebuffered saline containing 1% fetal bovine serum (FBS) and 0.1% NaN 3 (PBS-FBS buffer) followed by centrifugation at 1,200 rpm for 5 minutes at 4°C. Cells were triple color-stained with the following monoclonal antibodies: FITC-conjugated CD11b, F4/80 or CD19, PE-conjugated anti-H2°K b (for MHC I), MHC II, or CD4, and cychrome-conjugated CD3, with appropriate isotype controls, as suggested by the vendors. After incubating cells for 30 minutes at 4°C, cells were washed twice before suspending in 300 L phosphate-buffered saline. All antibodies were used at 1:100 dilution in PBS-FBS buffer, and all the washes were performed with PBS-FBS buffer followed by centrifugation at 1,200 rpm for 5 minutes. During acquisition of at least 50,000 counts by flow cytometry, a wide scatter gate was used to eliminate debris.
Mixed Lymphocyte Reaction
Mixed lymphocyte reaction (MLR) tests T-cell responsiveness to foreign histocompatibility antigens by measuring the proliferation of lymphocytes from one strain (responder cells) in the presence of allogeneic cells that are irradiated or treated with mitomycin C to prevent proliferation (stimulatory cells). Two days following burn injury or sham treatment, splenocytes were isolated. 4 Five ϫ 10 5 viable splenocytes (responder cells) were incubated with an equal number of mitomycin-treated allogenic splenocytes, or they were treated with mitomycin (stimulatory cells) before incubating with allogeneic cells. Proliferation was assessed by incorporation of a 4-hour pulse of 3 H-thymidine into newly synthesized DNA.
Computation of Net Change in Protein Loss and Statistical Analysis
To calculate the net change in protein loss, fractional changes in protein synthetic and degradation rates were calculated independently for each day using the equation ⌬Change x-y ϭ (x/yr) minus 1, where x and y are the measured synthetic or degradation rates in burned and sham animals, respectively. The following convention was used: increased degradation (positive fraction) and reduced synthesis (negative fraction) were considered to be additive since they contribute to the net loss of protein in a cell; decreased degradation (negative fraction) and increased synthesis (positive fraction) were considered to be additive for net gain of protein in a cell and are represented on the negative side of the y-axis. A one-way analysis of variance with 99% confidence interval was used to evaluate the significant differences.
RESULTS
Effect of IFN-␥ on Body Weight
Sham treatment had no effect either in the IFN-␥ -/-or in XMG1.2 antibody-treated animals relative to sham-treated WT controls for all the measured parameters (n ϭ 4 in each group). Thus, all sham values were averaged together for each time point (n ϭ 12) and used to compare the effect of burn trauma. General observations on IFN-␥ -/-mice for the first 4 to 5 days after 20% total body surface area burn injury indicated overall apparent health indistinguishable from sham-treated animals. Objectively, the reduction in overall body size that occurs with WT animals following burn was not seen. However, although all burned IFN-␥ -/-animals were well 2 days following injury, two of six animals eventually showed signs of sickness by day 6 (lethargy, diminished movement); elevated peripheral neutrophil counts on day 7 in these animals indicated the presence of infection. Results from these two animals were excluded from the final analysis. Burned WT animals treated with XMG1.2 antibody likewise showed overall health and activity comparable to sham animals.
WT animals showed a significant body weight loss by day 2 relative to sham animals ( Fig. 1 ). Since 20% burn injury without secondary complication is a nonlethal trauma model, WT animals eventually show a recovery to their initial body weight by day 7. In comparison, neither burninjured IFN-␥ -/-mice nor burn-injured WT mice receiving XMG1.2 antibody showed any body weight loss. Body weight gain in burned IFN-␥ -/-mice was similar to the sham and treated mice. After 7 days postinjury, the burninjured WT mice or burned WT mice receiving irrelevant antibodies isotype-matched to XMG1.2 (rat IgG 2a ) weighed about their initial body weight, which was significantly less than either the sham animals or WT mice receiving XMG1.2 antibody. 
Suppression of Skeletal Muscle Hypercatabolism in the Absence of IFN-␥
The loss in overall body weight after a traumatic condition is primarily due to the loss of skeletal muscle proteins as a consequence of upregulated proteolysis. Protein turnover rates were therefore measured in the fast-twitch EDL and slow-twitch soleus muscle (Fig. 2) . 4 In the first 2 days after burn injury, both EDL and soleus muscles from WT mice showed a significant increase in protein degradation (see Fig. 2A ); this increased proteolysis had normalized by day 7. This correlates with the loss of body weight during the study period. By comparison, EDL and soleus muscles from burn-injured IFN-␥ -/-mice or WT mice treated with XMG1.2 antibody showed no change in their protein degradation relative to sham animals. Protein synthetic rates in EDL and soleus from burn-injured WT mice were either reduced or there was no significant change (see Fig. 2B ). In the absence of IFN-␥, protein synthetic rates in the same muscle samples were not significantly affected and at some time points were even slightly greater than sham controls. Figure 2C shows the net changes in protein turnover. Burn injury induced significant muscle wasting (loss of protein) in WT EDL and soleus muscles during the first 2 days after injury relative to sham-treated animals; by day 7 there was a rebound with a net protein gain. In the absence of IFN-␥, protein loss during the first 2 days was not seen; in fact, on day 2 a significant net gain in the protein was observed in the EDL muscle. This net gain in protein is consistent with the overall body weight gain.
Absence of Hypercatabolism in Lymphoid Population
The changes in the protein turnover rates were computed using protein degradation and synthesis measurements in PBMNCs and splenocytes. 4 As shown in Figure 3A , the change in the protein degradation rates of burned WT splenocytes was similar to that observed for skeletal muscles. On days 1 to 2, there was a 30% to 40% increase in the degradation in burned animals, with return to sham levels by day 7. This increase in degradation was absent in the splenocytes from burned IFN-␥ -/-and WT antibody-treated animals. Protein degradation rates in PBMNCs from burned WT animals were consistently increased throughout the first 7 days; unlike skeletal muscle, protein degradation rate in WT PBMNCs was increased at day 7 by more than 70%. This increase in degradation was absent in the PBMNCs from the burned WT antibody-treated animals and diminished in burned IFN-␥ -/-mice. Protein synthetic rates in all the burned splenocytes or PBMNCs (see Fig. 3B ) were largely unchanged in IFN-␥ -/-or WT animals treated with XMG1.2 antibody. As shown in Figure 3C , in the absence of IFN-␥, there was either no net protein change or a modest net increase.
Effect of IFN-␥ on Lymphoid Subpopulations Following Trauma
IFN-␥ is integrally involved in regulating the immune response by a variety of mechanisms. Observed catabolic changes in WT animals could conceivably alter the ratio of lymphoid subpopulations or modulate surface molecule expression. To evaluate these possibilities, we counted the total number of viable cells recovered from spleens at each time point. As shown in Table 1 , on day 1 there was a significant decrease in all the burn group relative to the sham animals; the least effect was for the XMG1.2 antibody-treated group. By day 2, the only significant decrease was in the WT untreated group. By day 7, the trend was reversed and the burned WT untreated group showed a significant increase in the number of splenocytes; interestingly, the absence of IFN-␥ prevented the increase in the overall increase in cell number.
To dissect the changes in the three major subpopulations constituting the spleen, and circulating blood cells, the relative percentages of T cells (CD3ϩ), B cells (CD19ϩ), and macrophages/monocytes (CD11bϩ, F4/80) were measured by flow cytometry (see Table 1 ). Since CD11bϩ cells also include neutrophils, the relevant mononuclear cells were identified by gating for size and intracellular granularity; results were confirmed using the macrophage-specific marker F4/80 4 (data not shown). Absence of IFN-␥ transiently resulted in increased percentages of splenic T cells on day 1 after burn injury; by day 2, the percentages had normalized to the sham values. By day 7, WT burned animals showed a drop in T-cell counts not seen in IFN-␥ -/mice. PBMNCs showed no change in circulating T-cell percentages at any point or with any treatment.
All burned animals showed a significant drop in CD19ϩ cells relative to sham animals 1 day after burn injury. This B-cell depression persisted for WT burned animals but recovered by day 2 in the absence of IFN-␥. The monocyte/ macrophage population in splenocytes was uniformly depressed in all groups 1 day after burn injury. In the absence of IFN-␥, this largely normalized by day 2 in the WT burned animals, and there was a marked rebound in the monocyte/ macrophages by day 7 not seen in the absence of IFN-␥.
Effect on MHC Expression
A hypercatabolic state in lymphoid populations could conceivably contribute to the functional immune deficiency seen after burn injury; for example, altered protein turnover could modulate MHC expression or depress adhesion and/or costimulatory molecules pertinent to the immune response. We therefore used flow cytometry to assess whether IFN-␥ affects the surface expression of MHC I and/or II in PBMNCs and splenocytes following burn injury. As shown in Figure 4A , the CD19ϩ gated PBMNC population from 2-day-postburn WT animals showed either no change or a slight decrease in MHC I expression. In comparison, a subset of CD19ϩ PBMNCs from either IFN-␥ -/-or XMG1.2 antibody-treated animals showed increased MHC I expression relative to sham controls. By day 7 (see Fig.  4B ), burn injury markedly decreased the MHC I expression in a subset of CD19ϩ cells from WT animals. In contrast, 
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in the absence of IFN-␥, there was a population with an increased MHC I expression, and no population showed reduced MHC I expression.
This alteration was not globally observed in other subpopulations, particularly in the CD11bϩ population; in all the groups and at all time points there was no significant change in the MHC I expression level (data not shown). On day 7, CD3ϩ splenocytes from burned WT animals showed a global loss in their MHC I expression; this did not occur in the CD3ϩ populations of splenocytes from IFN-␥ -/-or XMG1.2 antibody-treated WT animals (not shown).
Alterations in the expression of MHC II were also analyzed. 19 Unlike the MHC I expression, there was no statistically significant and consistent alterations in any of the group of animals or cell populations (not shown).
Functional Ability of Lymphocytes Following Burn Injury
To establish a direct cause-and-effect relation between hypercatabolism and immune dysfunction, we performed MLR experiments in splenocytes obtained 2 days after burn injury (Fig. 5 ). We first analyzed the effect of burn injury on the proliferative response of T cells and cytokine production. If burn injury primarily affects T-cell function, T cells from burned animals will respond poorly regardless of the source of stimulator cells. As shown in Figure 5A , splenocytes from the burn injury animals showed a 50% decrease in their proliferation ability relative to the sham animals at all measured time points. Viability analysis of these splenocytes using propidium iodide staining after 4 days in MLR culture demonstrated similar viability in the lymphocytes from burned and sham animals (data not shown); consequently, burn-induced cell death does not explain diminished MLR responsiveness. On the other hand, splenocytes from the burned IFN-␥ -/-or XMG1.2 antibody-treated WT animals responded to allogeneic cells as well as splenocytes from sham animals. This suggests that burn injury impairs the functional responsiveness of T cells, and that this effect can be blocked by neutralizing the effect of IFN-␥ at the early stages of injury. We also tested whether burn injury affects the function of antigen-presenting cells (APCs) in an MLR, and specifically whether "sham" T cells will be stimulated less well by "burned" APCs than by "sham" APCs. Splenocytes from burn and sham animals were treated with mitomycin to arrest the proliferation and used as stimulators (see Fig. 5B ). The results show that stimulation by burned APCs resulted in proliferation that was only 50% of sham APCs, APCs from burned IFN-␥ -/-, or XMG1.2 antibody-treated animals at all measured time points. These results are consistent with the onset of hypercatabolic activity after burn injury and blockade of the effects by neutralization of IFN-␥. Comparable results were also obtained using PBMNCs (data not shown).
DISCUSSION
Our data demonstrate that congenital absence of IFN-␥ results in the normalization of a burn-induced hypercatabolic state with resulting weight gain, protein turnover, MHC expression, and lymphocyte responses comparable to sham-treated animals. That this is due to the absence of IFN-␥ and not a developmental defect in IFN-␥-deficit animals was confirmed by the administration of IFN-␥ blocking antibody to WT burned animals. The dosage and the interval of the neutralizing antibody administration were based on previous work in a heart transplant model. 18 The results shown here are obtained with only one dose administered shortly after injury.
IFN-␥ probably acts on skeletal muscle catabolism predominantly by increasing protein degradation. The mechanisms by which IFN-␥ controls protein degradation may be either direct or indirect. A direct effect correlating with the increased systemic IFN-␥ 20,21 could occur by modulating the intracellular components involved in proteolysis; for example, administration of IFN-␥ to healthy animals increases the ubiquitin mRNA expression. 14 Also, IFN-␥ can also potentially affect the ubiquitinating enzymes (E2s and E3s) or critical components of the proteasomal complex in the skeletal muscle. Another possible direct effect of IFN-␥ is suppression of endogenous insulin production by the ␤ cells of the pancreas. 22 This is an interesting possibility, especially in light of the beneficial effects of exogenous insulin administration in burn injury. 23, 24 Alternatively, IFN-␥ may act through secondary pathways by activating macrophages, which then produce mediators such as TNF-␣, IL-6, IL-1, prostaglandins, and nitric oxide.
This study also demonstrates early immune dysfunction after burn injury correlating with increased protein turnover; both protein catabolism and immune dysfunction are ameliorated by blockade of IFN-␥. Moreover, the significant early loss of splenocytes in WT animals was normalized by day 2 in the absence of IFN-␥ and remained unaltered by day 7. Thus, preventing the negative nitrogen balance at the early stages appears important not only to prevent muscle wasting but also to circumvent possible immune suppression. Although impaired immune responses following burn injury have been attributed to altered ratios of IFN-␥ (Th1 cytokine) versus IL-4 (Th2) cytokine, 25 IFN-␥ deficiency in this model actually results in improved MLR. To evaluate whether the absence of IFN-␥ drives Th2 response, circulating levels of IFN-␥ and IL-4 were measured by ELISA but were not detectable (data not shown).
Loss of proteins in immune cells could cause changes in their ability to regulate the expression of functionally important surface markers such as T-cell receptor, MHC I, MHC II, CD28, B7.1, or B7.2. For example, proteasomal catabolism directly affects MHC I expression by regulating NF-B nuclear translocation and subsequent MHC transcription. Moreover, both MHC I and MHC II levels are modulated by IFN-␥. 26 We analyzed MHC I and II expression in the lymphocyte subsets. In this work, we show that IFN-␥ negatively regulates MHC I expression in some 
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subpopulations in the context of burn injury. Interestingly, there was no change in the expression of MHC II in any lymphoid population, even though IFN-␥ is a major inducer of MHC II expression in a variety of inflammatory states. 12 However, the upregulation of MHC I expression in a subset of CD19ϩ cells, both in IFN-␥ -/-and XMG1.2 antibodytreated mice, suggests possible involvement of alternate cytokines such as type 1 interferons, which are known potent inducers of MHC I. 27 To correlate hypercatabolism to immune response, and to evaluate the dependency of immune dysfunction on IFN-␥, responses of splenocytes were evaluated using the MLR experiment. Burn injury has been reported to decrease the MLR responses of peripheral blood cells in humans. 28 In addition, Deitch et al. showed that both T and B cells from different lymphoid compartments show an early depression in their mitogen responsiveness. 29 Our results are consistent with these findings. It is interesting that both responders and stimulators from burned IFN-␥ -/-or XMG1.2 antibodytreated WT animals showed normal MLR responses, indicating that IFN-␥ is critical for inducing the functional deficit in both following burn injury. Also, since both T cells and APCs are impaired, this suggests that hypercatabolic activity in either stimulators or responders can diminish immune responses. It is noteworthy that the results shown used naive T cells in a primary MLR where the response is critically dependent on accessory cells expressing costimulatory molecules.
Based on transiently suppressed IFN-␥ levels in the circulation following injury, other groups have proposed treating immune dysfunction in burn injury by exogenous administration of IFN-␥. 30 It was noted in burned patients that there is an increase in circulating IFN-␥, followed by a decrease at the end of 2 days; IFN-␥ remains below normal for the next 3 to 4 days and then recovers back to normal or above normal during the later part of the traumatic condition (day 7 and above in mice). 21 Since a lower level of IFN-␥ precedes the immune dysfunction, it was hypothesized to be the driving force in immune dysfunction. In a clinical trial to prevent infection-related mortality after severe burn injury, IFN-␥ was administered to patients starting 1 to 4 days postinjury and continuing until day 90. 31 The outcome of this study indicated that exogenous IFN-␥ did not show any protective effect on the infection-related mortality; 30 in fact, there was a trend toward greater mortality overall in IFN-␥-treated patients. Our data here regarding IFN-␥-mediated muscle wasting and immune dysfunction provide an explanation for the negative effects of IFN-␥ administration in this clinical setting. It will be interesting to study the longterm effects of weekly dosage of the XMG1.2 antibody on the immune response and on wound healing, given the evidence that IFN-␥ reduces dermal collagen synthesis while increasing proteoglycan synthesis. 32 The infection in 2 of 18 burned INF-␥ -/-animals (2 of 6) was probably due to the inherent susceptibility that congenitally INF-␥ -/animals are prone. 17 This is not evident when animals do not develop infection in the absence of IFN-␥; in confirmation, we have concurrently presented the data on WT animals treated with IFN-␥ neutralizing antibodies. There was no infection in any of the antibody-treated animals during the entire study period, which suggests that it is not the neutralization/absence of IFN-␥ per se but rather that congenital absence predisposes animals to infection.
Understanding the events responsible for the production of IFN-␥ by activated T cells and natural killer cells may provide insight into the mechanism of the hypercatabolic state following trauma. There is substantial evidence that IL-18 (also called IFN-␥ inducing factor) regulates IFN-␥ protein. Interestingly, IL-18 is constitutively expressed in keratinocytes and other cells but not processed to an active form, 33 presumably until some activation event occurs. 34 One possible unifying hypothesis is that trauma (e.g., cutaneous burn) triggers the production of IL-18 from cells in the vicinity of the injury; this in turn activates the production of IFN-␥, which then is released into circulation and triggers a cascade of events culminating in muscle wasting and immune dysfunction.
In conclusion, the observation that trauma-induced hypercatabolism in IFN-␥ -/-animals is suppressed in both skeletal and lymphoid populations indicates a fundamental role for IFN-␥ in mediating the augmented protein turnover in multiple cell types. This suggests novel therapeutics that may not only inhibit muscle wasting but also modulate immune dysfunction. Analysis of the involvement of IFN-␥ in other trauma models or diseases where muscle wasting and immune dysfunction coexist, such as AIDS and cancer cachexia, may suggest strategies targeted at preventing the mortality and morbidity of these patients as well.
